ASHP CE Center

Log-in / Create Account

Session Information

2006 Midyear Clinical Meeting

Click here to go to the previous page

Drugs vs. Bugs: A Concise Review of Key Issues in Anti-Infective Therapeutics

Track: Programming for New Practitioners

Program Code: 307-L04

Date: Sunday, December 3, 2006

Time: 3:30 PM to 4:30 PM

Location: Ballroom E (CC)

MODERATOR:

Click the plus sign to see more detailed information about each speaker.

Douglas Slain

General Expertise/QualificationsRecognized infectious diseases expert and experienced invited speaker at regional and national meetings.Completed Infectious Diseases Residency and Fellowship training.Practices as an Infectious Diseases Specialist Selected as the �Clinician of the Year� by The Society of Infectious Diseases Pharmacists, 2007.Publications relevant to Health-care associated infectionsSlain D. Pneumonia [Chapter 75]. In: Helms RA, Eds. Textbook of Therapeutics: Drug and Disease Management, 8th edition. Lippincott Williams & Wilkins, Philadelphia. 2006 .Hodges B, Slain D. Pneumonia Case. In: Helms RA, Quan DJ, Eds. Casebook of the Textbook of Therapeutics: Drug and Disease Management, 8th edition. Lippincott Williams & Wilkins, Philadelphia. 2006 [in press].Slain D. Infections in immunocompromised patients (Chapter 132): A patient-focused approach. In: Schwinghammer TL, Ed. Pharmacotherapy Casebook and Instructor�s Guide, 6th Edition. McGraw-Hill, New York, 2005. Recent Presentations relevant to Health-care associated infectionsThe WVU Experience. Stewardship Tactics for Antimicrobial Resistance Trends (START Program). Pittsburgh, PA. August 24, 2007. Drugs vs. Bugs: A Concise Review of Key Issues in Anti-Infective Therapeutics. 41st Annual American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting. Anaheim, CA. December 9, 2003.Empiric Therapy Decisions for Serious Infections: A Consideration of Appropriate Therapy. Pharmacotherapy Grand Rounds. University of Tennessee, Memphis, TN November 16, 2006 Antimicrobials and Resistance. 2006 OVMC Infectious Diseases Symposium. Ohio Valley Medical Center, Wheeling, WV. October 7, 2006.Safeguards for Serious Infections: A Consideration of Appropriate Empiric Antibiotic Therapy. Virginia Society of Health-System Pharmacists Meeting, Region IV. Richmond, VA. October 27, 2005.Respected educator 2006-2007 WVU Outstanding Teacher

SPEAKER:

Click the plus sign to see more detailed information about each speaker.

Douglas Slain

Drugs vs. Bugs: A Concise Review of Key Issues in Anti-Infective Therapeutics

Description

Learning Objectives:

Describe the impact of, and emerging trends in, antimicrobial resistance on empiric therapy.

Explain common mechanisms of resistance expressed by bacterial and fungal pathogens.

Name two to three reasons adequate or appropriate first-Lineempiric therapy is important in light of current resistant trends.

Describe the clinical situations in which newer antimicrobials are most appropriate.

Handout Online
(Attendees only)

(Code: 307-L04)

Regular Attendee:Free

Attendees Login